FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4294309587> ?p ?o ?g. }

• W4294309587 endingPage "346" @default.
• W4294309587 startingPage "335" @default.
• W4294309587 abstract "El síndrome de Guillain-Barré es una polirradiculoneuropatía que se ha asociado con enfermedades infecciosas como desencadenantes. En la actualidad es escasa la evidencia médica que explore la relación entre el desarrollo del síndrome de Guillain-Barré causado por la infección por SARS-CoV-2 y la COVID prolongada. Sintetizar la evidencia médica que describe la relación entre el síndrome pos-COVID y el síndrome de Guillain-Barré en la población pediátrica. Se realizó una revisión exploratoria utilizando las bases de datos de Scopus y PubMed, incluyendo estudios experimentales y observacionales analíticos o descriptivos. Las principales manifestaciones clínicas presentadas por los pacientes fueron debilidad distal y ascendente en miembros inferiores y mialgias. El enfoque diagnóstico se apoyó en los hallazgos clínicos, hallazgos imagenológicos por resonancia magnética de columna y electromiografía. La estrategia terapéutica se basó en el uso de inmunoglobulinas humanas intravenosas. El síndrome de Guillain-Barré es una enfermedad frecuente en la población pediátrica con infección activa por SARS-CoV-2 o en sobrevivientes, sin embargo, es necesario incentivar el desarrollo de estudios clínicos que incrementen la literatura médica que describe esta asociación. Guillain-Barré syndrome is a polyradiculoneuropathy that has been associated with infectious diseases as triggers. There is currently little medical evidence exploring the relationship between the development of Guillain-Barré syndrome caused by SARS-CoV-2 infection and long Covid. To synthesize the medical evidence that describes the relationship between post Covid syndrome and Guillain-Barré syndrome in the paediatric population. A scoping review was developed using Scopus and PubMed databases, including analytical and/or descriptive experimental and observational studies. The main clinical manifestations presented by paediatric patients were distal and ascending weakness in the lower limbs and myalgia. The diagnostic approach was based on clinical findings, imaging findings on spinal magnetic resonance and electromyography. The therapeutic strategy is based on the use of intravenous human immunoglobulins. Guillain-Barré syndrome is a frequent disease in the paediatric population with active SARS-CoV-2 infection or in survivors, however, it is necessary to encourage further clinical studies that increase the medical literature that describes this association." @default.
• W4294309587 created "2022-09-02" @default.
• W4294309587 creator A5008233750 @default.
• W4294309587 creator A5008950330 @default.
• W4294309587 creator A5027106924 @default.
• W4294309587 creator A5031366163 @default.
• W4294309587 creator A5045516307 @default.
• W4294309587 creator A5051791553 @default.
• W4294309587 creator A5053499228 @default.
• W4294309587 creator A5058179119 @default.
• W4294309587 creator A5058440532 @default.
• W4294309587 creator A5058760554 @default.
• W4294309587 creator A5065594240 @default.
• W4294309587 creator A5069648757 @default.
• W4294309587 creator A5070807912 @default.
• W4294309587 creator A5073119553 @default.
• W4294309587 creator A5085500449 @default.
• W4294309587 date "2022-10-01" @default.
• W4294309587 modified "2023-10-01" @default.
• W4294309587 title "Síndrome de Guillain Barré en población pediátrica. ¿Consecuencia de la infección activa o de la covid prolongada?" @default.
• W4294309587 cites W2075950485 @default.
• W4294309587 cites W2084154288 @default.
• W4294309587 cites W2176685543 @default.
• W4294309587 cites W2891378911 @default.
• W4294309587 cites W2913767126 @default.
• W4294309587 cites W3037916911 @default.
• W4294309587 cites W3041568858 @default.
• W4294309587 cites W3042041520 @default.
• W4294309587 cites W3080188472 @default.
• W4294309587 cites W3085105835 @default.
• W4294309587 cites W3092136311 @default.
• W4294309587 cites W3094573100 @default.
• W4294309587 cites W3107196321 @default.
• W4294309587 cites W3110893147 @default.
• W4294309587 cites W3116855314 @default.
• W4294309587 cites W3120376855 @default.
• W4294309587 cites W3128623264 @default.
• W4294309587 cites W3133403973 @default.
• W4294309587 cites W3133940526 @default.
• W4294309587 cites W3134256435 @default.
• W4294309587 cites W3135006489 @default.
• W4294309587 cites W3135099638 @default.
• W4294309587 cites W3155941993 @default.
• W4294309587 cites W3159737251 @default.
• W4294309587 cites W3159849690 @default.
• W4294309587 cites W3160163127 @default.
• W4294309587 cites W3164430773 @default.
• W4294309587 cites W3164665330 @default.
• W4294309587 cites W3166454585 @default.
• W4294309587 cites W3177191943 @default.
• W4294309587 cites W3178580290 @default.
• W4294309587 cites W3189200245 @default.
• W4294309587 cites W3194700763 @default.
• W4294309587 cites W3195806484 @default.
• W4294309587 cites W3196026828 @default.
• W4294309587 cites W3213541515 @default.
• W4294309587 cites W3214447547 @default.
• W4294309587 cites W4211083796 @default.
• W4294309587 cites W4220654993 @default.
• W4294309587 doi "https://doi.org/10.1016/j.rcreu.2022.05.003" @default.
• W4294309587 hasPublicationYear "2022" @default.
• W4294309587 type Work @default.
• W4294309587 citedByCount "0" @default.
• W4294309587 crossrefType "journal-article" @default.
• W4294309587 hasAuthorship W4294309587A5008233750 @default.
• W4294309587 hasAuthorship W4294309587A5008950330 @default.
• W4294309587 hasAuthorship W4294309587A5027106924 @default.
• W4294309587 hasAuthorship W4294309587A5031366163 @default.
• W4294309587 hasAuthorship W4294309587A5045516307 @default.
• W4294309587 hasAuthorship W4294309587A5051791553 @default.
• W4294309587 hasAuthorship W4294309587A5053499228 @default.
• W4294309587 hasAuthorship W4294309587A5058179119 @default.
• W4294309587 hasAuthorship W4294309587A5058440532 @default.
• W4294309587 hasAuthorship W4294309587A5058760554 @default.
• W4294309587 hasAuthorship W4294309587A5065594240 @default.
• W4294309587 hasAuthorship W4294309587A5069648757 @default.
• W4294309587 hasAuthorship W4294309587A5070807912 @default.
• W4294309587 hasAuthorship W4294309587A5073119553 @default.
• W4294309587 hasAuthorship W4294309587A5085500449 @default.
• W4294309587 hasConcept C138885662 @default.
• W4294309587 hasConcept C142724271 @default.
• W4294309587 hasConcept C15708023 @default.
• W4294309587 hasConcept C187212893 @default.
• W4294309587 hasConcept C2778691916 @default.
• W4294309587 hasConcept C2779134260 @default.
• W4294309587 hasConcept C3008058167 @default.
• W4294309587 hasConcept C524204448 @default.
• W4294309587 hasConcept C71924100 @default.
• W4294309587 hasConceptScore W4294309587C138885662 @default.
• W4294309587 hasConceptScore W4294309587C142724271 @default.
• W4294309587 hasConceptScore W4294309587C15708023 @default.
• W4294309587 hasConceptScore W4294309587C187212893 @default.
• W4294309587 hasConceptScore W4294309587C2778691916 @default.
• W4294309587 hasConceptScore W4294309587C2779134260 @default.
• W4294309587 hasConceptScore W4294309587C3008058167 @default.
• W4294309587 hasConceptScore W4294309587C524204448 @default.
• W4294309587 hasConceptScore W4294309587C71924100 @default.
• W4294309587 hasIssue "4" @default.

• next